These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 16234629)

  • 21. The importance of reendothelialization after arterial injury.
    Versari D; Lerman LO; Lerman A
    Curr Pharm Des; 2007; 13(17):1811-24. PubMed ID: 17584110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
    Tschudi MR; Noll G; Lüscher TP
    Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial function and hypertension.
    Landmesser U; Drexler H
    Curr Opin Cardiol; 2007 Jul; 22(4):316-20. PubMed ID: 17556884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension.
    Brunner H; Cockcroft JR; Deanfield J; Donald A; Ferrannini E; Halcox J; Kiowski W; Lüscher TF; Mancia G; Natali A; Oliver JJ; Pessina AC; Rizzoni D; Rossi GP; Salvetti A; Spieker LE; Taddei S; Webb DJ;
    J Hypertens; 2005 Feb; 23(2):233-46. PubMed ID: 15662207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial function and dysfunction in heart failure.
    Ferrari R; Bachetti T; Agnoletti L; Comini L; Curello S
    Eur Heart J; 1998 Jul; 19 Suppl G():G41-7. PubMed ID: 9717055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial dysfunction in hyperglycemia as a trigger of atherosclerosis.
    Nakagami H; Kaneda Y; Ogihara T; Morishita R
    Curr Diabetes Rev; 2005 Feb; 1(1):59-63. PubMed ID: 18220582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The erectile-endothelial dysfunction nexus: new opportunities for cardiovascular risk prevention.
    Watts GF; Chew KK; Stuckey BG
    Nat Clin Pract Cardiovasc Med; 2007 May; 4(5):263-73. PubMed ID: 17457350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from the ONTARGET Trial Programme.
    Ruilope LM; Redón J; Schmieder R
    Vasc Health Risk Manag; 2007; 3(1):1-9. PubMed ID: 17583170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of exercise training on endothelial function in cardiovascular disease in humans.
    Walther C; Gielen S; Hambrecht R
    Exerc Sport Sci Rev; 2004 Oct; 32(4):129-34. PubMed ID: 15604930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential novel pharmacological therapies for myocardial remodelling.
    Landmesser U; Wollert KC; Drexler H
    Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of endothelial dysfunction in atherosclerosis.
    Davignon J; Ganz P
    Circulation; 2004 Jun; 109(23 Suppl 1):III27-32. PubMed ID: 15198963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial dysfunction.
    Endemann DH; Schiffrin EL
    J Am Soc Nephrol; 2004 Aug; 15(8):1983-92. PubMed ID: 15284284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial dysfunction: how can one intervene at the beginning of the cardiovascular continuum?
    Schmieder RE
    J Hypertens Suppl; 2006 Apr; 24(2):S31-5. PubMed ID: 16601559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pleiotropic effects of ARB in vascular endothelial progenitor cells.
    Matsuura K; Hagiwara N
    Curr Vasc Pharmacol; 2011 Mar; 9(2):153-7. PubMed ID: 21143169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between erectile dysfunction and cardiovascular disease. Part I: pathophysiology and mechanisms.
    Kapur V; Schwarz ER
    Rev Cardiovasc Med; 2007; 8(4):214-9. PubMed ID: 18192944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial dysfunction in heart failure: mechanisms and therapeutic approaches.
    Bauersachs J; Schäfer A
    Curr Vasc Pharmacol; 2004 Apr; 2(2):115-24. PubMed ID: 15320512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial dysfunction in morbid obesity.
    Mauricio MD; Aldasoro M; Ortega J; Vila JM
    Curr Pharm Des; 2013; 19(32):5718-29. PubMed ID: 23448493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How to improve endothelial repair mechanisms: the lifestyle approach.
    Möbius-Winkler S; Linke A; Adams V; Schuler G; Erbs S
    Expert Rev Cardiovasc Ther; 2010 Apr; 8(4):573-80. PubMed ID: 20397830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic interventions in endothelial dysfunction: endothelium as a target organ.
    Cooke JP
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-45-51. PubMed ID: 9422852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
    Meyers MR; Gokce N
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.